首页 正文

PCSK9 inhibitors conquer primary prevention: the VESALIUS-CV study

{{output}}
Elevated low-density lipoprotein cholesterol (LDL-C) represents a key causal factor in atherosclerotic cardiovascular disease. Robust evidence demonstrates that early, marked, and sustained reduction of LDL-C is associated with a significant decrease in the ri... ...